CCNE1 and lung cancer: Transgenic cyclin E1 triggers dysplasia and multiple pulmonary adenocarcinomas [19, 20], and the overexpression of cyclin E1 was suggested to contribute to cancer development or tumorigenesis in various types of cancer, including breast, colon, and lung cancers [21].